 Connection
Lisa Maier to Pulmonary Disease, Chronic Obstructive
This is a "connection" page, showing publications Lisa Maier has written about Pulmonary Disease, Chronic Obstructive.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.904 |
|
|
|
-
Liao SY, Petrache I, Fingerlin TE, Maier LA. Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases. Respir Med. 2021 01; 176:106275.
Score: 0.390
-
Varkey B, Maier LA. Chronic respiratory diseases: challenges in diagnosis and prevention. Curr Opin Pulm Med. 2015 Mar; 21(2):111-3.
Score: 0.262
-
Serban KA, Pratte KA, Strange C, Sandhaus RA, Turner AM, Beiko T, Spittle DA, Maier L, Hamzeh N, Silverman EK, Hobbs BD, Hersh CP, DeMeo DL, Cho MH, Bowler RP. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. EBioMedicine. 2022 Oct; 84:104262.
Score: 0.111
-
Obi ON, Judson MA, Birring SS, Maier LA, Wells AU, Lower EE, Baughman RP. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI). Respir Med. 2022 01; 191:106436.
Score: 0.101
-
Gingo MR, Silveira LJ, Miller YE, Friedlander AL, Cosgrove GP, Chan ED, Maier LA, Bowler RP. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J. 2008 May; 31(5):1005-12.
Score: 0.040
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|